- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Shukra Pharmaceuticals Ltd — Board Meeting, 13-11-2025: Board Meeting
13-11-2025 | 06:14 pm
13-11-2025 | 06:14 pm
Shukra Pharmaceuticals' Board approved the financial results for the quarter and half-year ended Sep 30, 2025. Q2 Net Profit came in at ₹0.79 Cr on ₹7.59 Cr revenue. H1 Net Profit was ₹1.03 Cr on ₹7.41 Cr revenue. The company's business was also reviewed.
No comments yet. Be the first to comment!